benzyl N-[4-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]carbamate

We are benzyl N-[4-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]carbamate CAS:1676-86-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:benzyl N-[4-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]carbamate
CAS.NO:1676-86-4
Molecular Formula:C15H18N2O5
Molecular Weight:306.31400

Synonyms:
N|A-Carbobenzoxylysine N-Carboxy Anhydride
NCA-N-|A-Benzyloxycarbonyl-L-lysine
Benzyl {4-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl}carbamate
N|A-Benzyloxycarbonyl-L-lysine Carboxyanhydride
Carbamic acid, N-[4-[(4S)-2,5-dioxo-4-oxazolidinyl]butyl]-, phenylmethyl ester
N|A-Benzyloxycarbonyl-L-lysine N-Carboxyanhydride
N6-Carbobenzoxy-L-lysine N-Carboxyanhydride
|A-Benzyloxycarbonyl-L-lysine N-Carboxyanhydride

Physical and Chemical Properties:
Density:1.248g/cm3
Boiling point: /
Melting point:/
Flash point:/
Refractive index:1.538

Specification:
Appearance:White to off-white powder
Purity:≥98%
Impurity: <1%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -0ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:A L-lysine derivative used in the preparation of Polylysine, a synthetic, basic poly-α-amino acid.

Related News: This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.3937-56-2 This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.4-mercapto-4-metilpentan-2-ona CAS:19872-52-7 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.2,6-Dimethylpyrazine CAS:108-50-9 The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.